Anna Gleason (@anna_gle) header
Anna Gleason (@anna_gle) profile picture

Producer @CNBCFastMoney / engagements ≠ endorsements

New York, NY
Joined January 2022
Anna Gleason retweeted
Do you have an elderly or disabled neighbor in NYC? Be a good neighbor and let them know about the free air conditioner program. If they earn $3473 or less a month, NYC will cover the costs of an A/C. Remember…last summer we had 95 degree weather. Look out for them
37
6,328
54
13,423
380,113
"We have potentially the best in class profile based on efficacy, safety, manufacturing and one of the futures I think for this field: combinability," says @StructureTx CEO Ray Stevens. He discusses $GPCR's portfolio as the company nears $6B in value. cnbc.com/video/2026/01/15/st…
3
1
7
5,206
Stay tuned for tomorrow's Fast Money Live! We can't wait🪩!
I got an exclusive look at the new New Year's Eve ball at One Times Square. You can find out more at Fast Money Live this Thursday, Dec. 11th!
7
3
15
16,696
20% upside for tech in 2026? That's Wedbush's @DivesTech's bull case! His views on the AI trade, $NVDA's latest bet, the market's biggest risks, and more cnb.cx/4pHUG3p
3
8
2
47
172,858
Who's the biggest winner in the biotech space? Leerink's David Risinger just upgraded $LLY to outperform and stuck a $1,104 price target on the GLP-1 giant. He lays out why he's getting bullish on M&A prospects and beyond cnb.cx/3LWDc4I
2
3
19
8,516
A biotech breakout filled with superlatives! $IBB having its best day since may, $LLY hitting a fresh record high, and more... @TimSeymour, @GuyAdami, @TimSeymour, and Dan Nathan break down the action cnb.cx/4oIPnRy
3
5
10
7,665
Insmed is nearly on pace with Palantir for gains this year - nearly tripling! What are the next catalysts for the high-flyer in the gene therapy space and beyond? @Insmed CEO Will Lewis breaks it down cnb.cx/49xvGHh
4
10
8,871
Biopharma companies are betting big on drugs that treat MASH, a serious liver disease linked to obesity and metabolic issues. @MadrigalPharma's MASH drug was the first to clear the FDA. $MDGL CEO Bill Sibold lays out the outlook for the space: cnbc.com/video/2025/10/16/ma…
4
2
16
7,550
$KVUE recovering some of Monday's losses after hours after the Trump administration linked its Tylenol product to autism Dr. @ashishkjha says health professionals will continue to push back on that claim, and breaks down what's next for the industry cnb.cx/3Kz6sxO
16
3
15
8,878
A new disruptor in the weight loss space? @SignosHealth nabbing FDA approval for the first-ever glucose monitoring system for weight management. CEO @sharamfm discusses the use case for wearable health tech amid sky-high demand for GLP-1 drugs: cnbc.com/video/2025/09/10/si…
7
4
8
11,396
"If you don't have innovation, you can't raise price..." Needham's Laura Martin breaks down what she calls $AAPL's disappointing iPhone 17 reveal, pricing problems, and lackluster AI capabilities for new hardware cnb.cx/3JX46Zq
10
4
1
32
9,359